Gerresheimer glass buys Vitro's 51 percent stake

Date: 22 April 2002
Source: FT

Date: 22 April 2002

From Finacial Times:"Vitro SA said it has sold its 51 pct stake in its Ampolletas SA unit to its joint venture partner in the company, Gerresheimer Glass AG, for 13.4 mln usd in cash.

Gerresheimer Glass owns the remaining 49 pct in Ampolletas, which specialises in glass packaging for the pharmaceutical industry.Vitro said it will use the proceeds from the sale to reduce debt.It said the sale in itself will also reduce its consolidated debt by 7.8 mln usd.

It said the sale forms part of the company's strategy of concentrating on its core businesses."

600450 Gerresheimer glass buys Vitro's 51 percent stake glassonweb.com

See more news about:

Others also read

William A. Wulfsohn, vice president and general manager of Nylon System for Honeywell International, has been named vice president of European coatings for PPG Industries (NYSE:PPG) and managing director of PPG Europe. "Bill will play a vital role in helping our European coatings businesses achieve their full potential," said Michael A.
Apogee Enterprises Inc. reported level sales but an increase in earnings for the third quarter of its fiscal 2003. Bloomington-based Apogee, which makes glass products and services, said the earnings increase was mainly the result of improvements in its architectural glass business.
Bystronic is to take over Armatec Vierhaus GmbH with effect from 1 January 2003. For Bystronic, a global supplier of system solutions for the manufacture of architectural and automotive glass, the takeover of Armatec, which specialises in laminated safety glass and handling systems, ideally complements the Bystronic portfolio.
The butterflies at Melbourne Zoo have gone upmarket with a new accommodation wing featuring Pilkington glass.
Owens-Brockway Glass Container Inc., an indirect wholly-owned subsidiary of Owens-Illinois, Inc., (NYSE: OI) announced today that is has closed on the sale of $175 million principal amount of its 8-3/4% Senior Secured Notes due November 15, 2012.
UCB reached an agreement with Solutia to acquire Solutia's Resins, Additives & Adhesives activity for $500 million, plus a $10 million exclusivity fee.

Add new comment